Low-level mpox transmission continues in many parts of the world, with Africa, Europe, and the Americas reporting the largest portion of recent cases, the World Health Organization (WHO) said in a monthly situation update yesterday, which covers cases reported in March.

Adding a caveat that a decline in surveillance may underestimate infections, the WHO said 466 new cases, 3 of them fatal, were reported in March. In Africa, the Democratic Republic of the Congo (DRC)—experiencing an outbreak of a novel clade 1 virus—reported the most cases.
Ten countries reported case rises in March, with the Republic of Congo reporting the largest rise in Africa. Other hot spots were the United Kingdom, Puerto Rico in the United States, and Vietnam.
The WHO said the risk is high for the DRC's general population and moderate for countries that have historically reported mpox infections and for men who have sex with men, gender-diverse people, and sex workers. The general population risk for countries that haven't experienced earlier outbreaks is low.
Over the past 6 months, monthly cases have fluctuated between 400 and 1,000 cases, with most reported in the Americas, Europe, and Africa. Though sexual encounters are the most common mode of transmission, patterns in Africa are more diverse and include the zoonotic route.
Advisers discuss mpox vaccine issues
WHO vaccine advisers met in March, and they said populations to consider for vaccination include adults and children in geographic areas with documented exposure risks, people with multiple sexual contacts, health workers with repeated exposure, and known contacts of infected people.
The group called for strong measures to promote mpox and vaccine research in Africa, along with equitable access to vaccines. The committee expects to release its final recommendations on mpox immunization in May.